Allied Market Research

2024

Latam Radiopharmaceuticals Market

LATAM Radiopharmaceuticals Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type and, by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

  • Sep 2024

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (10% Off) $3,075 $2,768
Business User License (10% Off) $4,245 $3,821
Enterprise License (10% Off) $6,270 $5,643
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  LATAM Radiopharmaceuticals Market Report Highlights

Aspects Details
icon_5
By Type
  • CONTRAST REAGENTS
  • NUCLEAR REAGENTS
icon_6
By Application
  • DIAGNOSTICS
  • DRUG DISCOVERY & DEVELOPMENT
  • R&D
icon_7
By Region
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_8
Key Market Players

Almac Group, AUSPEC Pharmaceuticals, Triad Isotopes, Jubilant Life Sciences Ltd., Amersham Health, McKesson Corporation, Biocad, NURIX Pharmaceuticals, Arc Evolution Corp., Mallinckrodt plc

Loading Table Of Content...

LATAM Radiopharmaceuticals Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com